Carret Asset Management LLC Cuts Stake in Xylem Inc. (NYSE:XYL)

Carret Asset Management LLC trimmed its position in shares of Xylem Inc. (NYSE:XYL) by 1.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 11,792 shares of the industrial products company’s stock after selling 160 shares during the period. Carret Asset Management LLC’s holdings in Xylem were worth $1,349,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of XYL. CWM LLC lifted its stake in shares of Xylem by 209.8% in the 3rd quarter. CWM LLC now owns 7,687 shares of the industrial products company’s stock worth $700,000 after purchasing an additional 5,206 shares during the period. AE Wealth Management LLC lifted its stake in shares of Xylem by 122.0% in the 3rd quarter. AE Wealth Management LLC now owns 19,369 shares of the industrial products company’s stock worth $1,763,000 after purchasing an additional 10,646 shares during the period. HB Wealth Management LLC lifted its stake in shares of Xylem by 13.0% in the 3rd quarter. HB Wealth Management LLC now owns 2,259 shares of the industrial products company’s stock worth $206,000 after purchasing an additional 259 shares during the period. Exchange Traded Concepts LLC lifted its stake in shares of Xylem by 7.6% in the 3rd quarter. Exchange Traded Concepts LLC now owns 38,862 shares of the industrial products company’s stock worth $3,538,000 after purchasing an additional 2,734 shares during the period. Finally, Riverwater Partners LLC raised its stake in Xylem by 9.1% during the 3rd quarter. Riverwater Partners LLC now owns 2,409 shares of the industrial products company’s stock worth $219,000 after acquiring an additional 200 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Down 0.5 %

Shares of XYL stock traded down $0.71 on Thursday, hitting $129.96. The stock had a trading volume of 296,441 shares, compared to its average volume of 1,145,717. The company has a quick ratio of 1.30, a current ratio of 1.76 and a debt-to-equity ratio of 0.22. The business has a 50 day moving average price of $127.30 and a 200 day moving average price of $113.22. The company has a market cap of $31.50 billion, a PE ratio of 48.04, a P/E/G ratio of 2.60 and a beta of 1.10. Xylem Inc. has a one year low of $87.59 and a one year high of $132.23.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.03. The firm had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.05 billion. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The firm’s quarterly revenue was up 40.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.92 earnings per share. Research analysts anticipate that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, February 20th. This is an increase from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 1.11%. Xylem’s payout ratio is currently 52.94%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Raymond James upgraded shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Citigroup lifted their price objective on shares of Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Stifel Nicolaus lifted their price objective on shares of Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. BNP Paribas began coverage on shares of Xylem in a research report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price objective on the stock. Finally, Royal Bank of Canada lifted their price objective on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 7th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $138.11.

Insiders Place Their Bets

In other news, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.